Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-18

FDA Approved: FLUOXETINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for fluoxetine hydrochloride from Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine hydrochloride (Fluoxetine hydrochloride)

Snippet

SUPPL AP for FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE)